Fibryga savings card: up to $2,500 off a year with commercial insurance

Fibryga is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Fibryga is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameFibryga

Authorized genericfibrinogen (human)

Regular genericfibrinogen (human)

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Fibryga?

The original

–

Brand nameThe maker’s card

Octapharma Copay Assistance Program

Savings card from Octapharma

No insuranceNeeds insuranceNo cash price listed.

Insurance · up to $2,500 off a year

Or call 1-800-554-4440.

In the maker’s words

“If you have patients currently being treated with fibryga, or if you're about to begin therapy, our copay program can offer them savings of up to $2,500 per year on the out-of-pocket costs associated with fibryga therapy.”

From the maker’s offer on fibrygausa.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Fibryga itself, from the same company, sold without the brand name, and usually for less. For now Fibryga is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Fibryga is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

FIBRYGA is a human fibrinogen concentrate indicated for:

fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency

treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.

Limitations of Use:

FIBRYGA is not indicated for dysfibrinogenemia.

Source: the FDA label for Fibryga (Octapharma USA Inc), August 5, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/fibryga/